Valeant shares dive despite CEO's return from illness

Shares of Valeant Pharmaceuticals are down sharply in morning trading Monday, amid ongoing turmoil over the embattled drugmaker's delayed financial results and its leader's health.

See Full Article

Even news Sunday that CEO Michael Pearson is returning immediately after nine weeks recovering from pneumonia and unspecified complications failed to buoy Valeant shares.

The shares are trading at less than one-third of their $263.81 high last August. That was right before Valeant's practice of buying rights to old drugs and jacking up the prices came under congressional scrutiny, and a few months before its questionable relationship with a drug distributor raised concerns about the accuracy of its financial reporting.

Valeant shares dropped $6.75, or 8.4 per cent, to $73.90 in midday trading Monday.

Investors appear to be reacting to Valeant's announcement in a statement Sunday that is withdrawing all its financial forecasts.

Nomura equity analyst Shibani Malhotra wrote Monday that while Pearson's return to the helm "is a positive," for the company, she's concerned by Valeant's decision to withdraw its 2016 guidance, which was confirmed just six weeks ago.

Valeant, based in Laval, Quebec, also again delayed announcing its preliminary fourth-quarter and 2015 financial results, which were to be released Monday. The company cited Pearson's return to work as the reason.

"Valeant won't turn around until it restores its credibility, and it doesn't help to bring back the CEO who created the questions about financial reporting on his watch and his handling of questions about Philidor," Erik Gordon, a professor and pharmaceuticals analyst at University of Michigan's Ross School of Business, wrote in an email.

Pearson's convalescence, and the limited information the company released about his condition, aren't the only concerns dragging down Valeant shares.

Last Tuesday, Valeant said it would delay filing its 2015 annual report with regulators while it sorts out its former relationship with the mail-order pharmacy Philidor. Valeant said it expected to lower reported 2014 earnings by about 10 cents per share and raise 2015 earnings by about 9 cents. That's because about $58 million in sales to Philidor were improperly recognized too early -- when they were delivered to Philidor, rather than when patients received the products.

Moody's Investor's Service on Tuesday revised Valeant's outlook to negative from stable, but noted that the amount of revenue misstated "appears relatively minor."

Valeant cut ties with Philidor last fall amid allegations that Philidor created a network of "phantom pharmacies" to steer pharmacy benefit managers toward Valeant's more-expensive drugs instead of cheaper alternatives.

Responding to public criticism over its huge price increases for some products, Valeant's interim CEO, Howard Schiller, on Feb. 2 told a House committee investigating high drug prices that he froze all of Valeant's price increases when he took over in January. He said Valeant would aim for more modest price increases in the future.

Schiller is to transition out of his temporary CEO duties but remain a member of Valeant's board. The board also decided to split the roles of chairman and CEO, both of which had been held by Pearson, and appoint Robert A. Ingram as chairman of the board. Ingram has been on Valeant's board since 2010 and previously served as chairman for a few months at the start of 2011.

The board said in the statement that planning for Pearson's successor and expanding Valeant's senior management "are high priorities."

Jeffrey Loo, equity analyst at S&P Global Market Intelligence, wrote Monday that "the return of Mr. Pearson and (Valeant's) efforts to build out its management team for succession planning should provide some stability" and that he maintains a "Buy" recommendation on the stock.



Advertisements

Latest Economic News

  • TransCanada sends more crews to Keystone pipeline leak

    Economic CTV News
    AMHERST, S.D. -- TransCanada Corp. says the company has sent additional crews and equipment to the site of a 210,000-gallon oil spill from its Keystone pipeline in South Dakota. TransCanada said Saturday it is making progress in its investigation into the spill cause on farmland in Marshall County, near the North Dakota border, about 250 miles (402 kilometres) west of Minneapolis. Source
  • U.S. treasury chief a Bond villain? Mnuchin OK with comparison

    Economic CTV News
    WASHINGTON -- U.S Treasury Secretary Steven Mnuchin said Sunday he had no idea that a photo of him and his wife posing with a sheet of newly printed money would go viral. And he said he's not bothered that some commentators suggested the pair looked like James Bond villains. Source
  • 'Never a dull moment': Lawsuit, NAFTA claim, Fairfax partnership spur optimism, tension in Churchill

    Economic CBC News
    The future of the rail line to Churchill remains uncertain after a week that involved a lawsuit, an international trade challenge and the entry of a new, powerful player into the picture. The week's developments have raised cautious optimism in northern Manitoba, but also questions about the future of Arctic shipping and of communities along the northern rail line. Source
  • Truckers take cautious approach to all-electric vehicles

    Economic CBC News
    All-electric trucks have the potential to save money for fleet operators, particularly if maintenance costs prove to be lower than diesel, but there are still some significant barriers to their adoption, according to trucking industry veterans. Source
  • How to buy a car without getting ripped off: CBC's Marketplace consumer cheat sheet

    Economic CBC News
    How a student gamed rewards points This Montreal law student student racked up enough free rewards points to travel the world. Here's how he did it: he used his credit card to buy silver coins from the Mint and collect rewards points, then deposited the coins and paid off the card. Source
  • Honda recalls Odyssey minivans after dozens of reported injuries

    Economic CBC News
    Honda is recalling about 900,000 of its Odyssey minivans because the second-row seats may tip forward if not properly latched.Honda recalls 2.1 million vehicles worldwide over fire riskPHOTOS | Owner of fire-razed Honda Accord wants action after company recallThe recall announced Saturday covers vehicles from the 2011-17 model years. Source
  • 'This is bunk': WestJet apologizes for misleading passengers about why it cancelled flights

    Economic CBC News
    In response to a CBC News investigation, WestJet has admitted it mistakenly told passengers that hurricane-related airport restrictions had forced it to cancel Turks and Caicos flights. The airline now says it actually cancelled flights from Oct. Source
  • BlackBerry COO Marty Beard resigning to deal with family situation: CP

    Economic CTV News
    TORONTO -- A person with knowledge of the situation says that BlackBerry Ltd.'s chief operating officer has resigned in order to deal with a family health issue. The source who spoke on condition of anonymity says that Marty Beard will leave the company effective Dec. Source
  • Loblaw pre-orders 25 Tesla electric trucks for undisclosed price

    Economic CTV News
    MONTREAL -- Loblaw Companies Ltd. says it is among the first purchasers of Tesla's new electric truck. Canada's largest supermarket chain (TSX:L) says it has pre-ordered 25 of the vehicles called the Tesla Semi. Source
  • Canadian funds like energy stocks despite potential rejection in Norway

    Economic CTV News
    CALGARY -- Oil and gas investments may have soured for managers of the Norwegian sovereign wealth fund but a Canadian fund says it has plenty of room for such securities in its portfolio. In a letter this week, Norway's central bank urged the Norwegian government to consider divesting oil and gas company shares held in the US$1-trillion oil fund to avoid the risk of permanently lower commodity prices. Source